Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
03/29/2012 | US20120077209 Protein biomarkers and therapeutic targets for autoimmune and alloimmune diseaes |
03/29/2012 | US20120077208 Use of carbamoyl phosphate synthetase 1 (cps) as a humoral biomarker for the diagnosis of tumour diseases and chronic inflammatory intestinal diseases |
03/29/2012 | US20120077207 CD86 and CD80 receptor competition assays |
03/29/2012 | US20120077206 Rapid Microbial Detection and Antimicrobial Susceptibility Testing |
03/29/2012 | US20120077205 Method for producing complex of biotin-labeled cypridina (cypridina noctiluca) luciferase with streptoavidin and method for stabilizing the same |
03/29/2012 | US20120077204 Detection of Protein Translocation by Beta-Galactosidase Reporter Fragment Complementation |
03/29/2012 | US20120077199 Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
03/29/2012 | US20120077192 Risk Assessment For Adverse Drug Reactions |
03/29/2012 | US20120077188 Methods for manipulating liquid substances in multi-chambered receptacles |
03/29/2012 | US20120077184 Electromagnetic multiplex assay biosensor |
03/29/2012 | US20120076900 Cooker and control method thereof |
03/29/2012 | US20120076871 Method for detecting, quantifying and mapping damage and/or repair of dna strands |
03/29/2012 | US20120076851 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
03/29/2012 | US20120076826 Recombinantly Produced Allergens |
03/29/2012 | US20120076815 Identification and characterization of racemases, definition of protein signatures, and a test for detecting d-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase |
03/29/2012 | US20120076803 Antibodies to troponin i and methods of use thereof |
03/29/2012 | US20120076797 Modulation of kit signaling and hematopoietic cell development by IL-4 receptor modulation |
03/29/2012 | US20120076788 C-cbl and antagonists thereof for the treatment and diagnosis of cancer |
03/29/2012 | US20120076774 Detection and/or treatment of diseases associated with autoantibodies |
03/29/2012 | US20120076731 Lymphedema associated genes and model |
03/29/2012 | US20120076729 Methods of treating cancers |
03/29/2012 | US20120076725 Lung cancer markers, and uses thereof |
03/29/2012 | US20120076724 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
03/29/2012 | US20120076722 Methods for treating cancers and diseases associated with 4-1bb (cd137) expression |
03/29/2012 | US20120076693 Capillary flow test assembly |
03/29/2012 | US20120075616 Whole blood immunity measuring device and whole blood immunity measuring method |
03/29/2012 | US20120074308 Immunosuppressant monitoring by maldi mass spectrometry |
03/29/2012 | US20120074073 Fluid concentrator |
03/29/2012 | US20120073993 Electrowetting pumping device and application to electric activity measurements |
03/29/2012 | US20120073987 Electrochemical method and apparatus of identifying the presence of a target |
03/29/2012 | US20120073986 Electrochemical Test Device |
03/29/2012 | US20120073969 Amelioration of Heterophile Antibody Immunosensor Interference |
03/29/2012 | US20120073585 Methods of predicting complication and surgery in crohn's disease |
03/29/2012 | US20120073358 Electrodeposited gold nanostructures |
03/29/2012 | DE19648719B4 Verfahren zum Prüfen von manometrischen Meßgeräten für die Messung des biochemischen Sauerstoffbedarfs Method for testing manometric instruments for the measurement of biochemical oxygen demand |
03/29/2012 | DE102010046851A1 Detecting device for use in exhaust gas system for detecting nitrogen oxide contents in gas mixture from diesel combustion engine, has wall guiding gas stream to outlet opening after passing gas to sensor that is arranged in hollow body |
03/29/2012 | DE102010006956B4 Verfahren und Messgerät zum Messen der Sauerstoffsättigung im Blut Method and instrument for measuring the oxygen saturation in the blood |
03/29/2012 | DE102008059779B4 Verfahren für die Elektronentransfer-Dissoziation in Massenspektrometern und Massenspektrometer mit einer vakuuminternen Elektronenanlagerungsionenquelle zur Herstellung von Radikal-Anionen für eine Elektronentransfer-Dissoziation von Biopolymeren Method for the electron transfer dissociation in mass spectrometers and mass spectrometer with an internal vacuum electron attachment ion source for the production of radical anions for electron transfer dissociation of biopolymers |
03/29/2012 | DE102008011283B4 Markerfreies Chromosomenscreening Marker chromosome Free Screening |
03/29/2012 | CA2813011A1 Methods and compositions for the evaluation of renal injury using hyaluronic acid |
03/29/2012 | CA2812416A1 Human b1 cells and uses thereof |
03/29/2012 | CA2812291A1 Methods and reagents for signal amplification |
03/29/2012 | CA2812208A1 Synthesis of fluorescent noble metal nanoparticles |
03/29/2012 | CA2811822A1 Serum preparation |
03/29/2012 | CA2811706A1 Immunochromatography devices, methods, and kits |
03/29/2012 | CA2811678A1 Novel method for diagnosing lyme disease using a cellular immunological test |
03/29/2012 | CA2811658A1 Biomarkers of renal injury |
03/29/2012 | CA2811654A1 Biomarkers associated with pre-diabetes, diabetes and diabetes related conditions |
03/29/2012 | CA2811558A1 Breast cancer diagnostics |
03/29/2012 | CA2811543A1 Method for regulating the formation of a fibrous web |
03/29/2012 | CA2811394A1 Multimedia evaluation of butanol-containing fuels |
03/29/2012 | CA2811323A1 System for molecular packing calculations |
03/29/2012 | CA2811070A1 Use of myeloid cell biomarkers for the diagnosis of cancer |
03/29/2012 | CA2811023A1 Influenza treatment and/or characterization; human-adapted ha polypeptides; vaccines |
03/29/2012 | CA2810771A1 Low cut water sampling device |
03/29/2012 | CA2810039A1 Compositions and methods for detecting cancer metastasis |
03/28/2012 | EP2434290A1 Blood coagulation time prolonging agent |
03/28/2012 | EP2434289A1 Whole blood immunity measuring device and whole blood immunity measuring method |
03/28/2012 | EP2434288A1 Means and methods for diagnosing and/or treating a subject at risk of developing heart failure |
03/28/2012 | EP2434287A1 Means and methods for diagnosing and/or treating a subject at risk of developing heart failure |
03/28/2012 | EP2434286A2 Immunoassay reagents and methods of use thereof |
03/28/2012 | EP2434285A1 Breast cancer diagnostics |
03/28/2012 | EP2434284A1 Tube for measuring bio-related substance and quantifying system |
03/28/2012 | EP2434283A2 Diagnosis of preeclampsia |
03/28/2012 | EP2434282A2 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers |
03/28/2012 | EP2434024A1 Urine markers for detection of bladder cancer |
03/28/2012 | EP2434023A1 Urine markers for detection of bladder cancer |
03/28/2012 | EP2434022A2 Use of A33 antigens and JAM-IT |
03/28/2012 | EP2434019A1 Process for the production of fine chemicals |
03/28/2012 | EP2434010A1 Prophylactic and/or therapeutic agent for metabolic syndrome |
03/28/2012 | EP2434009A1 Modulation of WRN-mediated telomere-initiated cell signaling |
03/28/2012 | EP2433964A1 Peptide inducing xage-1b-specific immune reaction and utilization of same |
03/28/2012 | EP2433651A1 Method for detecting aldehydes and ketones in glycerine |
03/28/2012 | EP2433639A2 Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy |
03/28/2012 | EP2433143A2 Multi-directional microfluidic devices and methods |
03/28/2012 | EP2433141A2 Tissue analysis |
03/28/2012 | EP2433140A2 Systems and methods for determining the percentage of glycated hemoglobin |
03/28/2012 | EP2433139A1 Post-translation modified cardiac troponin t as a biomarker of a risk for heart failure |
03/28/2012 | EP2433138A1 Method for detecting a wound infection |
03/28/2012 | EP2433137A1 Methods of renal cancer detection |
03/28/2012 | EP2433136A1 Kits for and methods of differential staining of cervical cancer cells and/or tissues |
03/28/2012 | EP2433135A1 Method for the qualitative and/or quantitative analysis of tumour cells |
03/28/2012 | EP2433134A1 Assay methods for the determination of fkbpl expression level in the context of breast cancer |
03/28/2012 | EP2433133A2 Mitochondrial activity inhibitors of cancer-initiating cells and use thereof |
03/28/2012 | EP2433132A2 Compositions and methods for the detection of hiv-1/hiv-2 infection |
03/28/2012 | EP2433131A1 Particles and methods for long wavelength sers |
03/28/2012 | EP2433130A2 Device and method for isolating biological or chemical targets |
03/28/2012 | EP2433129A1 Sensor device for magnetic particles with a high dynamic range |
03/28/2012 | EP2433128A1 Conjugate having cleavable linking agent |
03/28/2012 | EP2433127A1 Composite animal litter material and methods |
03/28/2012 | EP2433126A1 Methods for analyzing agricultural and environmental samples using microfluidic systems |
03/28/2012 | EP2433125A1 Method for determining the cardio-generative potential of mammalian cells |
03/28/2012 | EP2433124A1 Methods for providing personalized medicine tests ex vivo for hematological neoplasms |
03/28/2012 | EP2433123A1 Method for analyzing axon growth |
03/28/2012 | EP2433122A2 Multilayer colorimetric sensor arrays |
03/28/2012 | EP2433121A1 Thermally stable sers taggants |
03/28/2012 | EP2433112A2 Multilayer colorimetric sensors |
03/28/2012 | EP2433103A1 Device for an axial load gauge |
03/28/2012 | EP2432897A1 Methods for whole-cell analysis of gram-positive bacteria |
03/28/2012 | EP2432894A1 Glucose sensor calibration |